Dengue, Urbanization and globalization: The unholy trinity of the 21 st century

Tropical Medicine and Health

Volumn 39, Issue 4 SUPPL., 2011, Pages 3-11

  Gubler, Duane J ^a  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Aedes aegypti; Dengue; Globalization; Urbanization

Indexed keywords

ANTIVIRUS AGENT; DENGUE VACCINE; LIVE VACCINE;

AEDES AEGYPTI; DENGUE; DISEASE CARRIER; DISEASE CONTROL; DISEASE TRANSMISSION; EPIDEMIC; GLOBAL CHANGE; HUMAN; INCIDENCE; INFECTION PREVENTION; MOSQUITO; NONHUMAN; REVIEW; TROPICS; URBAN AREA; URBANIZATION; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 84863823773     PISSN: 13488945     EISSN: 13494147     Source Type: Journal    
DOI: 10.2149/tmh.2011-S05     Document Type: Review

References (63)

1. Henderson DA. Surveillance Systems and Intergovernmental Cooperation. In: Stephen S. Morse, ed. Emerging Viruses. Oxford University Press; pp. 283-289, 1993.
2. Gubler DJ. Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: Top Down or Bottom Up. Am J Trop Med Hyg 1989; 40: 571-578.
3. IOM (Institute of Medicine). 1992. Emerging infections: microbial threats to health in the United States. Washington, DC: National Academy Press.
4. Gubler DJ. The President's Address: Prevention and control of tropical diseases in the 21st century: Back to the field. Am J Trop Med Hyg 2001; 65(1): v-xi.
5. Gubler DJ. The global threat of emergent/reemergent vectorborne diseases. In: Vector-Borne Diseases: understanding the environmental, human health, and ecological connections; Institute of Medicine. Washington, D.C.: The National Academies Press; 2008, pp. 43-64.
6. Gubler DJ. Population growth, urbanization, automobiles and airplanes: The dengue connection. In: Greenwood B, De Cock K, eds. New and Resurgent Infections: Prediction, Detection and Management of Tomorrow's Epidemics. London: London School of Hygiene and Tropical Medicine; 1998. pp. 117-129.
7. Gubler DJ. Dengue and Dengue Hemorrhagic Fever: Its History and Resurgence as a Global Public Health Problem. In: Gubler DJ, Kuno G, eds. Dengue and Dengue Hemorrhagic Fever. London: CAB International; 1997. pp. 1-22.
8. Kimura R, Hotta S. Studies on dengue fever (VI). On the inoculation of dengue virus into mice. (In Japanese.) Nippon Igaku 1944; 3379: 629-633.
9. Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg 1952; 1: 30-50.
10. Hammon WM. Dengue hemorrhagic fever-Do we know its cause? Am J Trop Med Hyg 1973; 22: 82-91.
11. Technical Advisory Committee on Dengue Haemorrhagic Fever for the South East Asian and Western Pacific Regions. Guide for Diagnosis, Treatment and Control of Dengue Haemorrhagic Fever. 2nd ed. Geneva: World Health Organization; 1980. pp. 1-30.
12. Laigret J, Rosen L, Schollhammer G. Sur une epidemie de dengue survenue a Tahiti en 1964. Relations avec les feivres hemorragiques du sud-est asiatique. Bulletin de la Societe de Pathologie Exotique 1967; 60: 339-353.
13. Moreau J-P, Rosen L, Saugrain J, Lagraulet J. An epidemic of dengue on Tahiti associated with hemrrohagic manifestations. Am J Trop Med Hyg 1973; 22: 237-241.
14. Barns WJS, Rosen L. Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island. Am J Trop Med Hyg 1974; 23: 495-506.
15. Loison G, Rosen L, Papillaud J, Tomasini J, Vaujany J, Chanalet G. La dengue en Nouvelle-Caledonie (1971-1972). Bulletin de la Societe de Pathologie Exotique 1973; 66: 511-519.
16. Maguire T, Miles JAR, MacNamara FN, Wilkinson PJ, Austin FJ, Mataila JU. Mosquito-borne infections in Fiji V. The 1971-72 dengue epidemic. J Hyg (Cambridge) 1974; 73: 263-270.
17. Gubler DJ, Reed D, Rosen L, Hitchcock JC. Epidemiologic, clinical and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg 1978; 27: 581-589.
18. Rosen L. The pathogenesis of dengue haemorrhagic fever. A critical appraisal of current hypothese. S Afr Med J 1986; Suppl: 40-42.
19. Steel A, Gubler DJ, Bennett SN. Natural attenuation of dengue virus type-2 after a series of island outbreaks: A retrospective phylogenetic study of events in the South Pacific three decades ago. Virology 2010 Sep 30; 405(2): 505-512.
20. Schliessman DJ, Calheiros LB. A review of the status of yellow fever and Aedes aegypti eradication programs in the Americans. Mosquito News 1974; 34: 1-9.
21. Dengue in the Caribbean, 1977. Scientific Publication No. 375. Pan American Health Organization, 1979, p. 186.
22. PAHO 1994. Dengue and Dengue Hemorrhagic Fever in the Americas: Guidelines for Prevention and Control. Scientific Publication No 548.
23. Gubler DJ, Trent DW. Emergence of Epidemic dengue/ Dengue Hemorrhagic Fever as a public health problem in the Americas. Infect Agents Dis 1994; 2: 383-393.
24. Beatty ME, Letson GW, Margolis HS. Estimating the Global Burden of Dengue. In: Abstract Book: Dengue 2008. The Second International Conference on Dengue and Dengue Haemorrhagic Fever. Phuket, Thailand
25. Sumarmo Wulur H, Jahya E, Gubler DJ, Sutomenggolo TS, Sulianti Saroso J. Encephalopathy associated with dengue infection. Lancet 1977; 8061: 449-450.
26. Sumarmo Wulur H, Jahya E, Gubler DJ, Sorensen K. Clinical observations virologically confirmed fatal Dengue Hemorrhagic Fever in Jakarta, Indonesia. Bull World Health Organ 1983; 61: 693-701.
27. Kho LH, Sumarmo Wulur H, Jahya EC, Gubler DJ. Dengue Hemorrhagic Fever accompanied by encephalopathy in Jakarta. Southeast Asian J Trop Med Public Health 1981; 12: 83-86.
28. Phuong CXT, et al. Evaluation of the World Health Organization standard tourniquet test in the diagnosis of dengue infection in Vietnam. Trop Med Int Health 2002; 7: 125-132.
29. Balmaseda A, et al. Assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am J Trop Med Hyg 2005; 73: 1058-1062.
30. Nimmannitya S, Thisyakorn U. Dengue Hemorrhagic Fever with Unusual Manifestations. In: Proceedings of the International Conference on Dengue/Dengue Haemorrhagic Fever. Kuala Lumpur, Malaysia; 1983.
31. WHO. 2009. Dengue. Guidelines for Diagnosis, Treatment, Prevention and Control. World Health Organization. Geneva, Switzerland.
32. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 2011; 84: 200-207.
33. Suaya JA, Shepard DS, Beatty M, Farrar J. Disease burden of dengue fever and dengue hemorrhagic ffever. Preedy VR, Watson RR, eds. Handbook of Disease Burdens and Quality of Life Measures. New York: Springer; 2010, pp. 1263-1279.
34. Gubler DJ, Meltzer M. The Impact of Dengue/Dengue Hemorrhagic Fever on the Developing World. Adv Virus Res 1999; 53: 35-70.
35. Dechant EJ, Riagu-Perez JG. Hospitalizations for suspected dengue in Puerto Rico, 1991-1995: estimation by capturerecapture methods. The Puerto Rico Association of Epidemiologists. Am J Trop Med Hyg 1999; 61: 574-578.
36. Gubler DJ, Sather GE, Kuno G, Cabral AJR. Dengue 3 transmission in Africa. Am J Trop Med Hyg 1986; 35: 1280-1284.
37. Gubler DJ. Dengue and Dengue Hemorrhagic Fever. Clin Microbiol Rev 1998; 11(3): 480-496.
38. Gubler DJ. Epidemic dengue/Dengue Hemorrhagic Fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10: 100-103.
39. WHO. Dengue and dengue haemorrhagic fever. Factsheet N° 117, revised May 2008. Geneva, World Health Organization, 2008 (http://www.who.int/mediacentre/factsheets/ fs117/en/).
40. Gubler DJ. How effectively is epidemiological surveillance used for dengue programme planning and epidemic response? Dengue Bulletin 2002; 26: 96-106.
41. Newton EAC, Reiter P. A model of the transmission of dengue fever with an evaluation of the impact of ultra-low volume (ULV) insecticide applications on dengue epidemics. Am J Trop Med Hyg 1992; 47: 709-720.
42. Reiter P. Aedes alpobictus and the world trade in used tires, 1988-1995: The shape of things to come? J Am Mosq Cont Assoc 1998; 14: 83-94.
43. Gubler DJ. Dengue/dengue haemorrhagic fever: history and current status. In: Novartis Foundation Symposium 277: New Treatment Strategies for Dengue and Other Flaviviral Diseases. John Wiley & Sons, Ltd.; 2006, pp. 3-22.
44. Alirol E, Getaz L, Stoll B, Chappuis F, Loutan L. Urbanisation and infectious diseases in a globalised world. Lancet Infect Dis 2011; 11: 131-141.
45. Wilcox BA, Gubler DJ, Pizer HF. Urbanization and the Social Ecology of Emerging Infectious Diseases. Chapter 4. In: Mayer K, Pizer HF, eds. Social Ecology of Infectious Diseases. London: Academic Press (Elsevier, Inc); 2008.
46. IATA, 2011, http://www.iata.org/ps/intelligence_statistics/ Pages/index.aspx
47. WHO. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization; 1997.
48. Gubler DJ, Suharyono W, Sumarmo, Wulur H, Jahya E, Sulianti Saroso J. Virological surveillance for Dengue Hemorrhagic Fever in Indonesia using the mosquito inoculation technique. Bull World Health Organ 1979; 57: 931-936.
49. Cummings DA, et al. Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand. Nature 2004; 427: 344-347.
50. Gubler DJ. Cities spawn epidemic dengue viruses. Nat Med 2004; 10: 129-130.
51. Gubler DJ. The emergence of epidemic dengue fever and dengue hemorrhagic fever in the Americas: a case of failed public health policy. Pan Am J Public Health 2005; 17(4): 221-224.
52. McCall PJ, Kittayapong K. (2007) Control of dengue vectors: tools and strategies. Report of the Scientific Working Group meeting on Dengue, Geneva, 1-5 October 2006. pp. 110-119.
53. Alphey L, Benedict MQ, Bellini R, Clark GG, Dame D, Service M, Dobson S. Sterile-insect methods for control of mosquito-borne diseases-an analysis. Vector Borne and Zoonotic Diseases 2010; 10: 295-311.
54. Kay B, Vu SN. New strategy against Adedes aegypti in Vietnam. Lancet 2005; 365: 613-617.
55. McMeniman CJ, O'Neil SL. A virulent Wolbachia infection decreases the viability of the dengue vector. Aedes aegypti during period of embryonic quiescence. PLoS Negl Trop Dis 2010; 4: e748.
56. Wise de Valdez MR, Nimmo D, Betz J, Gong H, James AA, Alphey L, Black WC IV. Genetic elimination of dengue vector mosquitoes. Proc Nat Acad Sci (U S A) 2011; 108: 4772-4775.
57. Keller TH, Chen YL, Know JE, Lim SP, Ma NL, Patel SJ, Sampath A, Wang QY, Yin Z, Vasudevan SG. Finding new medicines for flaviviral targets. In: Novartis Foundation Symposium 277: New Treatment Strategies for Dengue and Other Flaviviral Diseases. John Wiley & Sons, Ltd; 2006, pp. 41-56.
58. Patkar CG, Kuhn RJ. Development of novel antivirals against flaviviruses. In: Novartis Foundation Symposium 277: New Treatment Strategies for Dengue and Other Flaviviral Diseases. John Wiley & Sons, Ltd; 2006, pp. 102-119.
59. Whitehead SS, Blaney JE, Durbin AP, Murphy BR. Prospects for a dengue virus vaccine. Nat Rev Microbiol 2007; 5: 518-528.
60. Wilder-Smith A, Ooi EE, Vasudevan SG, Gubler DJ. Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep 2010; 12: 157-164.
61. Tien NT, Luxemburger C, Toan NT, Pollissard-Gadroy L, Huong VT, Van Be P, Rang NN, Wartel TA, Lang J. A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam. Trans R Soc Trop Med Hyg 2010; 104: 592-600.
62. Swaminathan S, Batra G, Khanna N. Dengue vaccines: state of the art. Expert Opin Ther Pat 2010; 20(6): 819-835.
63. Gubler DJ. Emerging vector-borne flavivirus diseases: are vaccines the solution? Expert Rev Vaccines 2011; 10: 563-565.